ask Ask a question
Favorite

The APACT 4S Plus aggregometer (LABiTec, Ahrensburg, Germany) was used for LTA as previously published [17]. Platelet rich plasma (PRP) was obtained by centrifugation of citrate-anticoagulated whole blood at 150× g for 10 min at room temperature. Subsequently, platelet poor plasma (PPP) was generated by re-centrifugation of the remaining specimen at 2000× g for 10 min. The light transmittance of PPP was considered as 100% aggregation. Thrombin receptor-activating peptide (TRAP; 25 µM; Rolf Greiner BioChemica, Flacht, Germany) was used as agonist to initiate platelet aggregation. Maximal aggregation % was calculated by comparing the increase in light transmittance through PRP after addition of TRAP to the optical density of PPP.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A